BRPI0416377A - processo para a sìntese de imidazóis - Google Patents

processo para a sìntese de imidazóis

Info

Publication number
BRPI0416377A
BRPI0416377A BRPI0416377-0A BRPI0416377A BRPI0416377A BR PI0416377 A BRPI0416377 A BR PI0416377A BR PI0416377 A BRPI0416377 A BR PI0416377A BR PI0416377 A BRPI0416377 A BR PI0416377A
Authority
BR
Brazil
Prior art keywords
synthesis process
imidazole synthesis
imidazoles
preparation
active compounds
Prior art date
Application number
BRPI0416377-0A
Other languages
English (en)
Inventor
Lloyd J Dolby
Shervin Esfandiari
Michael E Garst
Original Assignee
Allergan Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Allergan Inc filed Critical Allergan Inc
Publication of BRPI0416377A publication Critical patent/BRPI0416377A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"PROCESSO PARA A SìNTESE DE IMIDAZóIS". A presente invenção fornece um processo para a preparação de imidazóis, reagindo um composto de ciano com um composto de isocianeto de silil-alquila. Tais imidazóis são compostos farmacologicamente ativos úteis e/ou intermediários úteis para a preparação de compostos farmacologicamente ativos.
BRPI0416377-0A 2003-11-11 2004-11-05 processo para a sìntese de imidazóis BRPI0416377A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/706,474 US7183305B2 (en) 2003-11-11 2003-11-11 Process for the synthesis of imidazoles
PCT/US2004/037154 WO2005047267A1 (en) 2003-11-11 2004-11-05 Process for the synthesis of imidazoles

Publications (1)

Publication Number Publication Date
BRPI0416377A true BRPI0416377A (pt) 2007-04-03

Family

ID=34552554

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0416377-0A BRPI0416377A (pt) 2003-11-11 2004-11-05 processo para a sìntese de imidazóis

Country Status (7)

Country Link
US (2) US7183305B2 (pt)
EP (1) EP1682517A1 (pt)
JP (1) JP2007512250A (pt)
AU (1) AU2004289685A1 (pt)
BR (1) BRPI0416377A (pt)
CA (1) CA2545742A1 (pt)
WO (1) WO2005047267A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7323485B2 (en) * 2002-05-21 2008-01-29 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
US7091232B2 (en) * 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds
US7358269B2 (en) 2002-05-21 2008-04-15 Allergan, Inc. 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronapthalen-1(2H)-one
US20080188527A1 (en) * 2003-12-23 2008-08-07 Cashman John R Synthetic Compounds and Derivatives as Modulators of Smoking or Nicotine Ingestion and Lung Cancer
AU2015279377B2 (en) 2014-06-26 2019-09-12 F. Hoffmann-La Roche Ag Indolin-2-one or pyrrolo-pyridin-2-one derivatives

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4771117A (en) * 1987-04-30 1988-09-13 E. I. Du Pont De Nemours And Company Polymerization of acrylic esters
FR2696177B1 (fr) 1992-09-28 1995-05-12 Synthelabo Dérivés de pipéridine, leur préparation et leur application en thérapeutique.
DE69432263T2 (de) 1993-11-15 2003-12-04 Schering Corp., Kenilworth Phenylalkyl-imidazole als h3-rezeptor-antagonisten
PL322028A1 (en) 1995-03-01 1998-01-05 Yamanouchi Pharma Co Ltd Derivatives of imidazoles and pharmaceutic composition containing them
FR2732017B1 (fr) 1995-03-21 2000-09-22 Inst Nat Sante Rech Med Nouveaux derives de l'imidazole antagonistes et/ou agonistes du recepteur h3 de l'histamine, leur preparation et leurs applications therapeutiques
US5658903A (en) 1995-06-07 1997-08-19 Smithkline Beecham Corporation Imidazole compounds, compositions and use
IL119701A0 (en) 1996-11-26 1997-02-18 Novadent Ltd Device and method for the ultrasonic detection of dental caries
US6235740B1 (en) 1997-08-25 2001-05-22 Bristol-Myers Squibb Co. Imidazoquinoxaline protein tyrosine kinase inhibitors
KR20010031839A (ko) 1997-11-07 2001-04-16 둘락 노먼 씨. 한 개의 질소원자를 함유하는 5, 6 또는 7원헤테로사이클릭 환으로 치환된 이미다조일알킬
EP1045846B1 (en) 1997-11-28 2003-05-02 Lg Chemical Limited Imidazole derivatives having an inhibitory activity for farnesyl transferase and process for preparation thereof
US6329369B1 (en) 1997-12-04 2001-12-11 Allergan Sales, Inc. Methods of treating pain and other conditions
US6841684B2 (en) * 1997-12-04 2005-01-11 Allergan, Inc. Imidiazoles having reduced side effects
US6008240A (en) 1997-12-15 1999-12-28 Gliatech, Inc. 2-(1H-4(5)-imidazoyl) cyclopropyl derivatives
US6133291A (en) 1998-10-16 2000-10-17 Schering Corporation N-(imidazolylalkyl)substituted cyclic amines as histamine-H3 agonists or antagonists
KR20010011698A (ko) 1999-07-30 2001-02-15 김선진 라스 변이세포의 성장을 억제하는 티오우레아 유도체 또는 이들의 무독성염
US7091232B2 (en) * 2002-05-21 2006-08-15 Allergan, Inc. 4-(substituted cycloalkylmethyl) imidazole-2-thiones, 4-(substituted cycloalkenylmethyl) imidazole-2-thiones, 4-(substituted cycloalkylmethyl) imidazol-2-ones and 4-(substituted cycloalkenylmethyl) imidazol-2-ones and related compounds

Also Published As

Publication number Publication date
US20070185332A1 (en) 2007-08-09
CA2545742A1 (en) 2005-05-26
WO2005047267A1 (en) 2005-05-26
JP2007512250A (ja) 2007-05-17
US7598394B2 (en) 2009-10-06
US7183305B2 (en) 2007-02-27
EP1682517A1 (en) 2006-07-26
AU2004289685A1 (en) 2005-05-26
US20050101785A1 (en) 2005-05-12

Similar Documents

Publication Publication Date Title
NO20065178L (no) Tienopyridinderivater
BRPI0516911A (pt) método para a preparação de um composto e composto de anilina
DK1537097T3 (da) Fremgangsmåde til fremstilling af 3-Halo-4,5-dihydro-1H-pyrazoler
BRPI0416869A (pt) 5,7-diaminopirazolo '4,3-dipirimidinas com atividade de inibição de pde-5
EA200601847A1 (ru) Замещённые метиларил- или гетероариламидные соединения
CA2565660A1 (en) Ortho substituted aryl or heteroaryl amide compounds
DE60311646D1 (de) 1-substituierten imidazol derivaten als nos inhibitoren
GB0127903D0 (en) Improvements relating to organic compounds
BR0313917A (pt) Composições antimicrobianas
EA199900821A1 (ru) Способ получения производных пиразола
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
IL178839A0 (en) Heterocyclic condensed compounds useful as antidiuretic agents
SE0103710D0 (sv) Compounds
EA200400454A1 (ru) Мускариновые агонисты
BRPI0416377A (pt) processo para a sìntese de imidazóis
GB0317920D0 (en) Solid-phase synthesis
CY1112279T1 (el) Εποξειδικη ενωση και μεθοδος για την παρασκευη της
CA2495628A1 (fr) Nouveau procede de synthese du (7-methoxy-3,4-dihydro-1-naphtalenyl)acetonitrile et application a la synthese de l'agomelatine
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
GB0327323D0 (en) Novel pharmaceuticals
BR0313976A (pt) Compostos de 7-fenilpirazolopiridina
ATE441642T1 (de) Hydantoin derivate mit affinität für somatostatin rezeptoren
DK1105392T3 (da) Fremgangsmåde til fremstilling af mellemprodukter for imidazodiazepin
TW200730480A (en) Organic compounds
BRPI0414511A (pt) composto, composições farmacêuticas, e, uso de um composto

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11Y Definitive dismissal acc. article 33 of ipl - extension of time limit for request of examination expired